Seroprevalence comparison of different varicella vaccines among Turkish children.
作者信息
Choi BongKyoo, Kwon ShiNae
机构信息
Department of Research and Development, GC Pharma, Yongin, South Korea.
Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, South Korea.
出版信息
Hum Vaccin Immunother. 2022 Nov 30;18(5):2067443. doi: 10.1080/21645515.2022.2067443. Epub 2022 Apr 21.
Abstract
摘要
相似文献
1
Seroprevalence comparison of different varicella vaccines among Turkish children.土耳其儿童中不同水痘疫苗的血清流行率比较
Hum Vaccin Immunother. 2022 Nov 30;18(5):2067443. doi: 10.1080/21645515.2022.2067443. Epub 2022 Apr 21.
2
Seroprevalence of varicella antibodies in adults without clinical history of disease.成人中无疾病临床史的水痘抗体血清阳性率。
Cad Saude Publica. 2020 Jan 20;36(1):e00149119. doi: 10.1590/0102-311X00149119. eCollection 2020.
3
Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany.德国水痘疫苗接种前时代儿童和青少年的水痘-带状疱疹病毒血清流行率
BMC Infect Dis. 2017 May 19;17(1):356. doi: 10.1186/s12879-017-2461-2.
4
Analysis of sero-epidemiological characteristics of varicella in healthy children in Jiangsu Province, China.中国江苏省健康儿童水痘血清流行病学特征分析。
BMC Infect Dis. 2018 Nov 14;18(1):563. doi: 10.1186/s12879-018-3496-8.
5
Long -term persistence of antibodies against varicella in fully immunized healthcare workers: an Italian retrospective cohort study.完全免疫的医护人员中针对水痘带状疱疹病毒的抗体长期持久性：一项义大利回顾性队列研究。
BMC Infect Dis. 2021 May 25;21(1):475. doi: 10.1186/s12879-021-06180-x.
6
Varicella seroprevalence and vaccine uptake in preschool children.
Med J Aust. 2005 Jan 3;182(1):42. doi: 10.5694/j.1326-5377.2005.tb06555.x.
7
Response to a letter to the editor regarding ' the comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka'.对一封致编辑的信的回复，该信涉及“土耳其儿童接种不同水痘疫苗（MAV/06和vOka）的血清转化率比较”。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2073760. doi: 10.1080/21645515.2022.2073760. Epub 2022 May 16.
8
[Investigation on sera prevalence rate of varicella and immunogenicity of varicella vaccine in healthy children].
Zhonghua Liu Xing Bing Xue Za Zhi. 1998 Oct;19(5):271-3.
9
Susceptibility to varicella in childbearing age women, Central Italy: is there a need for vaccinating this population group?意大利中部育龄妇女对水痘的易感性：是否有必要为这一人群接种疫苗？
Vaccine. 2007 Aug 10;25(32):6086-8. doi: 10.1016/j.vaccine.2007.05.019. Epub 2007 Jun 4.
10
Prevalence of IgG varicella zoster virus antibodies in the Kuikuro and Kaiabi indigenous communities in Xingu National Park, Brazil, before varicella vaccination.巴西欣古国家公园库伊库鲁和凯亚比土著社区在水痘疫苗接种前水痘带状疱疹病毒IgG抗体的流行情况。
Rev Inst Med Trop Sao Paulo. 2005 May-Jun;47(3):139-42. doi: 10.1590/s0036-46652005000300004. Epub 2005 Jul 12.
引用本文的文献
1
Analysis of antibody dynamics in Chinese children aged 1-3 years after single-dose varicella vaccination: A 42 months prospective study.1-3 岁儿童单剂水痘疫苗接种后抗体动态分析：42 个月前瞻性研究。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2410065. doi: 10.1080/21645515.2024.2410065. Epub 2024 Oct 16.
2
Response to a letter to the editor regarding ' the comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka'.对一封致编辑的信的回复，该信涉及“土耳其儿童接种不同水痘疫苗（MAV/06和vOka）的血清转化率比较”。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2073760. doi: 10.1080/21645515.2022.2073760. Epub 2022 May 16.
本文引用的文献
1
Letter to the Editor: Effectiveness of the Varicella Vaccine Among Korean Children: Suggestions for Future Research.致编辑的信：水痘疫苗在韩国儿童中的有效性：对未来研究的建议。
J Korean Med Sci. 2022 Jan 3;37(1):e17. doi: 10.3346/jkms.2022.37.e17.
2
The comparison of seroconversion rates among different varicella vaccines administered Turkish children; MAV/06 and vOka.比较不同水痘疫苗在土耳其儿童中的血清转化率：MAV/06 和 vOka。
Hum Vaccin Immunother. 2021 Nov 2;17(11):4190-4193. doi: 10.1080/21645515.2021.1967037. Epub 2021 Oct 13.
3
Waning Effectiveness of One-dose Universal Varicella Vaccination in Korea, 2011-2018: a Propensity Score Matched National Population Cohort.2011-2018 年韩国一剂次通用水痘疫苗效力降低：一项倾向评分匹配的全国人群队列研究。
J Korean Med Sci. 2021 Sep 13;36(36):e222. doi: 10.3346/jkms.2021.36.e222.
4
Letter to the Editor: Effectiveness of the Varicella Vaccine in Korea: Unresolved Issues.致编辑的信：韩国水痘疫苗的有效性：未解决的问题。
J Korean Med Sci. 2021 Jul 12;36(27):e200. doi: 10.3346/jkms.2021.36.e200.
5
Immunogenicity and safety profiles of a new MAV/06 strain varicella vaccine in healthy children: A multinational, multicenter, randomized, double-blinded, active-controlled phase III study.一种新的 MAV/06 株水痘减毒活疫苗在健康儿童中的免疫原性和安全性特征：一项多中心、随机、双盲、阳性对照、III 期多国研究。
Vaccine. 2021 Mar 19;39(12):1758-1764. doi: 10.1016/j.vaccine.2021.02.013. Epub 2021 Feb 21.
6
Letter to the Editor: Epidemiological Comments on the Effectiveness of the Varicella Vaccine in Korea.致编辑的信：关于韩国水痘疫苗有效性的流行病学评论
J Korean Med Sci. 2020 Jul 20;35(28):e265. doi: 10.3346/jkms.2020.35.e265.
7
Increasing varicella incidence rates among children in the Republic of Korea: an age-period-cohort analysis.韩国儿童水痘发病率上升：一项年龄-时期-队列分析。
Epidemiol Infect. 2019 Jan;147:e245. doi: 10.1017/S0950268819001389.
8
Trends in varicella and herpes zoster epidemiology before and after the implementation of universal one-dose varicella vaccination over one decade in South Korea, 2003-2015.韩国实施十余年水痘单剂疫苗普遍接种前后（2003-2015 年）水痘和带状疱疹流行病学趋势。
Hum Vaccin Immunother. 2019;15(11):2554-2560. doi: 10.1080/21645515.2019.1603985. Epub 2019 May 7.
9
Epidemiological Impact of the Korean National Immunization Program on Varicella Incidence.韩国国家免疫计划对水痘发病率的流行病学影响。
J Korean Med Sci. 2019 Feb 7;34(7):e53. doi: 10.3346/jkms.2019.34.e53. eCollection 2019 Feb 25.
10
Effectiveness of Varicella Vaccination Program in Preventing Laboratory-Confirmed Cases in Children in Seoul, Korea.韩国首尔水痘疫苗接种计划在预防儿童实验室确诊病例方面的有效性。
J Korean Med Sci. 2016 Dec;31(12):1897-1901. doi: 10.3346/jkms.2016.31.12.1897.
Zotero 插件